Digital Hive Mind was contracted by Vertex Pharmaceuticals, a global biotech company headquartered in Boston, MA, to provide product photography and capture video of the packaging process to support the launch of TRIKAFTA, the first triple combination therapy approved for the treatment of cystic fibrosis (CF) in patients 12 years and older with the most common CF gene mutation. TRIKAFTA was approved by the U.S. Food and Drug Administration (FDA) on October 21, 2019.
